Britannia Life Sciences Inc.
BLAB
CNSX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 459.09% | -47.03% | -61.18% | -70.48% | -49.14% |
| Total Receivables | -82.22% | -19.60% | -5.47% | -26.99% | -24.37% |
| Inventory | -- | 223.74% | -22.51% | -5.35% | -- |
| Prepaid Expenses | 80.85% | 37.11% | 17.34% | 68.67% | -45.66% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 242.68% | -30.28% | -37.01% | -48.32% | -35.38% |
|
|
|||||
| Total Current Assets | 242.68% | -30.28% | -37.01% | -48.32% | -35.38% |
| Net Property, Plant & Equipment | -81.32% | -7.61% | 3.58% | 3.67% | 59.30% |
| Long-term Investments | -- | -1.75% | 9.64% | -0.48% | 2.24% |
| Goodwill | -- | -1.75% | 9.64% | -0.48% | 2.24% |
| Total Other Intangibles | -- | 103.88% | 98.76% | 62.61% | 30.63% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | -50.87% | -11.40% | -4.55% | -13.21% | -5.54% |
|
|
|||||
| Total Accounts Payable | -12.88% | -34.66% | -4.92% | 4.03% | 5.88% |
| Total Accrued Expenses | 91.91% | 147.53% | 65.69% | -3.26% | 105.62% |
| Short-term Debt | -81.22% | -78.22% | -76.21% | 18.76% | 22.44% |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -92.21% | 15.03% | 29.13% | 5.96% | 7.95% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | -67.23% | 89.40% | 116.17% | 104.67% | 128.22% |
|
|
|||||
| Total Current Liabilities | -67.23% | 89.40% | 116.17% | 104.67% | 128.22% |
| Long-Term Debt | -69.49% | -21.72% | -14.03% | -28.18% | -24.30% |
| Short-term Debt | -81.22% | -78.22% | -76.21% | 18.76% | 22.44% |
| Capital Leases | -63.88% | 381.82% | 376.64% | 297.46% | 283.97% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -85.80% | -95.28% | -97.51% | -98.08% |
| Total Liabilities | -67.92% | 35.48% | 42.88% | 23.38% | 24.76% |
|
|
|||||
| Common Stock & APIC | -5.79% | -7.46% | 10.84% | 7.10% | 18.74% |
| Retained Earnings | 27.90% | -55.72% | -70.45% | -44.96% | -45.28% |
| Treasury Stock & Other | -22.10% | 109.22% | -57.36% | -147.68% | -142.00% |
| Total Common Equity | 143.49% | -86.29% | -80.75% | -75.59% | -65.32% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 143.49% | -86.29% | -80.75% | -75.59% | -65.32% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | 7.16% | 7.38% | -7.14% | 4.72% |
| Total Equity | -11.01% | -54.99% | -49.31% | -50.07% | -39.75% |
|
|
|||||